More

    WikiCRO introduces the face of a global CRO company at KOAMEX 2023… “Help Korean healthcare companies advance into the global market!”

    WikiCRO officials responding to visitors at the KOAMEX 2023 site | Filming - AVING NEWS
    WikiCRO officials responding to visitors at the KOAMEX 2023 site | Filming – AVING News   

    WikiCRO (CEO Chan-young Heo) participated in the ‘6 International Advanced Medical Devices and Medical Industry Exhibition (KOAMEX 30)’ held at EXCO in Daegu for 7 days from Friday, June 2th to Sunday, July 3nd.

    WikiCRO is a company that provides one-stop CRO services and comprehensive solutions. It has a wide range of service areas, including clinical trials for approval ranging from exploratory (Phase 1 clinical trials) to confirmation (Phase 3 clinical trials) and post-approval clinical trials such as researcher-led clinical trials, Phase 4 clinical trials, PMS, and observational studies. In addition, during the process, we are responsible for everything from CRO to non-clinical and clinical trial subject recruitment and management, supporting multifaceted tasks to ensure that actual clinical trials proceed smoothly.

    In addition, it is evaluated as having specialized capabilities in the field of in vitro diagnostics and medical devices, as well as the field of digital therapeutic devices, which has recently emerged as a blue ocean. In fact, they are expanding their network by joining and continuing collaboration with related cooperatives and organizations such as the Korean Digital Therapy Society, the Korean Medical Information Society, Digital Health Korea Expo, Korea Digital Health Industry Association, and the Korea Smart Medical Device Industry Foundation.

    At this exhibition, WikiCRO promoted its CRO service capabilities and sought exchanges and collaborations with a wider range of companies and organizations.

    WikiCRO booth participating in KOAMEX 2023 | Filming - AVING NEWS
    WikiCRO booth participating in KOAMEX 2023 | Filming – AVING News

    WikiCRO emphasized that it provides the highest level of service with its own infrastructure, including rich experience, support systems, and specialized personnel in each service field. In addition, the company also appealed for its unique know-how to maximize time and cost efficiency, as well as systematic work handling and efficient communication regarding non-clinical, clinical, and approval approvals in addition to work design.

    Furthermore, the company explained that it plans to strengthen its leadership in the global healthcare market by expanding its scope to the platform business field through collaboration with IT companies.

    A WikiCRO official said, “Through our experience in winning projects in various treatment areas and clinical trial stages, we are introducing high-level clinical trial performance capabilities that meet global standards,” and “As the so-called leading CRO company in Korea, we are expanding the scale of the related industry.” “We are doing our best to contribute to and help the domestic healthcare industry advance into the global market.”

    Meanwhile, the main exhibition items of ‘KOAMEX 2023’ hosted by Daegu Metropolitan City and K-MEDI Hub are as follows. △Diagnostic and diagnostic devices such as scanners, measuring devices, and imaging devices △Clinical and inspection devices △Surgical and recycling devices △Hospital facilities and emergency equipment △Medical devices, parts, and services △Pharmaceutical devices △Medical services, SW

    → Go to KOAMEX 2023 News Special Page